Lumida
/CRVL
⌘K
CorVel Corp

CorVel Corp

CRVL
$68.68USD-2.43%-1.71 today

MARKET CAP

3.5B

P/E (TTM)

34.7x

FWD P/E

DAY RANGE

$68 – $70

52W RANGE

$45
$93

AI Summary

Stalk
StalkMedium

CRVL is in a Stage 2 acceleration driven by a Momentum Breakout; price is in extreme overbought territory and pulling back into rising EMAs, making timing unfavorable now. We will stalk for a disciplined pullback into the 9EMA or 20EMA as entry zones.

  • Q2 revenue reached $260M, up 11% YoY driven by patient management services
  • EPS rose to $0.63 (+22% YoY) with free cash flow of $43.1M
  • Elevated self-insurance healthcare costs weigh on profit margins
Full analysis →

Buying

8

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY5.14 M321.32 M+262.51 K+20.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL1.53 M95.63 M+-88.30 K+8.2%0.13%
AC

Aqr Capital Management LLC

Q2 2026

BUY359.00 K22.44 M+228.96 K+215.8%0.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY150.10 K9.38 M+8.22 K+21.0%0.01%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

BUY116.02 K7.25 M+50.27 K+101.9%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL108.60 K6.78 M+-26.69 K-7.6%0.00%
MM

Millennium Management LLC

Q2 2026

BUY100.81 K6.30 M+32.08 K+67.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL66.19 K4.14 M+-30.96 K-22.1%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY25.40 K1.39 M+12.70 K+61.7%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY21.85 K1.37 M+11.14 K+133.5%0.01%
BA

Bridgewater Associates, LP

Q2 2026

BUYNEW18.42 K1.15 M+18.42 K+0.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL16.99 K1.06 M+-13.22 K-35.7%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL10.20 K637.58 K+-64.22 K-84.3%0.00%
VI

Voloridge Investment Management, LLC

Q2 2026

SELL0.000.00+-74.01 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-19.41 K-100.0%0.00%